The President and Chief Executive Officer of SELLAS Life Sciences Group, Inc. is Dr. Angelos M. Stergiou. Having founded the late-stage clinical biopharmaceutical enterprise, Dr. Stergiou oversees its comprehensive oncology pipeline, directing clinical trials and guiding strategic developments for innovative immunotherapeutic cancer treatments.